Viking Therapeutics Inc (NASDAQ:VKTX) has a beta value of 0.65 and has seen 1.08 million shares traded in the recent trading session. The company, currently valued at $2.82B, closed the recent trade at $3710000.0 per share which meant it gained $3709973.99 on the day or 1084490% during that session. The VKTX stock price is 100.0% off its 52-week high price of $81.73 and 100.0% above the 52-week low of $18.92. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.4 million shares traded. The 3-month trading volume is 3.71 million shares.
The consensus among analysts is that Viking Therapeutics Inc (VKTX) is Buy stock at the moment, with a recommendation rating of 1.21. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 0 out of 7 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Over the past 30 days, the shares of Viking Therapeutics Inc (NASDAQ:VKTX) have changed -7.82%. Short interest in the company has seen 26.71 million shares shorted with days to cover at 8.75.
Wall Street analysts have a consensus price target for the stock at $75, which means that the shares’ value could drop -4946566.67% from the levels at last check today.. The projected low price target is $75.0 while the price target rests at a high of $75.0. In that case, then, we find that the latest price level in today’s session is 100.0% off the targeted high while a plunge would see the stock lose 100.0% from the levels at last check today..
Viking Therapeutics Inc (VKTX) estimates and forecasts
The company’s shares have lost -46.21% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.00% over the past 5 years.
VKTX Dividends
Viking Therapeutics Inc is expected to release its next earnings report on 2025-Apr-23 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders
Insiders own 2.12% of the company shares, while shares held by institutions stand at 70.03% with a share float percentage of 71.55%. Investors are also buoyed by the number of investors in a company, with Viking Therapeutics Inc having a total of 499.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 16.54 million shares worth more than $876.8 million. As of 2024-06-30, FMR LLC held 14.9835% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 10.1 million shares as of 2024-06-30. The firm’s total holdings are worth over $535.26 million and represent 9.147% of shares outstanding.
